# Aura Biosciences, Inc.: Form 8-K, filed Jun 11, 2026

- Company: [Aura Biosciences, Inc.](/companies/aura.md) (CIK 1501796)
- Form: 8-K
- Filed: 2026-06-11
- Accepted by EDGAR: Jun 11, 2026, 16:31 ET
- Period: 2026-06-11
- Accession: 0001193125-26-267676
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1501796/000119312526267676/aura-20260611.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1501796/000119312526267676/

## Items reported

- Item 5.07: Shareholder vote results

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1501796/000119312526267676/aura-20260611.htm

Filed Jun 11, 2026.
Source: SEC EDGAR, the filing index for accession 0001193125-26-267676. Last ingested by Listed: Nov 14, 2026, 18:49 ET. No prices; not investment advice.
